SSRIs are considered first-line pharmacological treatments for Obsessive-Compulsive Disorder and related conditions. Unlike other anxiety or mood disorders, OCD often requires higher therapeutic doses and longer treatment durations to achieve meaningful symptom reduction.

SSRIs work by increasing the availability of serotonin in the brain, a neurotransmitter involved in mood regulation, anxiety control, and impulse management.

Common SSRIs used in OCD treatment may include:

• Fluoxetine
• Sertraline
• Fluvoxamine
• Paroxetine
• Escitalopram

Patients may require gradual dose adjustments and extended treatment timelines, as symptom improvement in OCD can take longer than in other mental health conditions. At SNBCare, providers closely monitor response, side effects, and adherence to ensure optimal outcomes.

For individuals who do not experience adequate symptom relief with SSRIs alone, antipsychotic augmentation may be considered. Low-dose second-generation antipsychotics can enhance the effectiveness of SSRIs by targeting additional neurochemical pathways involved in obsessive thinking and compulsive behaviors.

Common augmentation options may include:

• Risperidone
• Aripiprazole
• Quetiapine (in select cases)

Antipsychotic augmentation is prescribed cautiously, following evidence-based guidelines, and always with close clinical oversight. Patients receive clear education regarding potential benefits and risks to support informed decision-making.

Medication management at SNBCare is not a one-time intervention. It involves:

• Regular follow-up appointments
• Symptom tracking and outcome monitoring
• Side-effect assessment
• Adjustments based on treatment response

All care is delivered in a secure, HIPAA-compliant environment, prioritizing patient safety, confidentiality, and long-term wellness.